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Abstract 26 
Mouse disease models have proven indispensable in glaucoma research, yet the complexity 27 
of the vast number of models and mouse strains has also led to confusing findings. In this 28 
study, we evaluated baseline intraocular pressure, retinal histology, and retinofugal 29 
projections in three mouse strains commonly used in glaucoma research, i.e. C57Bl/6, 30 
C57Bl/6-Tyrc, and CD-1 mice. We found that the mouse strains under study do not only 31 
display moderate variations in their intraocular pressure, retinal architecture, and retinal 32 
ganglion cell density, also the retinofugal projections to the dorsal lateral geniculate nucleus 33 
and the superior colliculus revealed striking differences, potentially underlying diverging 34 
optokinetic tracking responses and visual acuity. Next, we reviewed the success rate of three 35 
models of (glaucomatous) optic neuropathies (intravitreal N-methyl-D-aspartic acid injection, 36 
optic nerve crush, and laser photocoagulation-induced ocular hypertension), looking for 37 
differences in disease susceptibility between these mouse strains. Different genetic 38 
backgrounds and albinism led to differential susceptibility to experimentally induced retinal 39 
ganglion cell death among these three mouse strains. Overall, CD-1 mice appeared to have 40 
the highest sensitivity to retinal ganglion cell damage, while the C57Bl/6 background was 41 
more resistant in the three models used. 42 
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Highlights 47 
• C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice were studied 48 
• Intraocular pressure, retinal histology, and RGC density varied in these strains 49 
• Different retinofugal projections to the dLGN and SC were observed 50 
• Optokinetic tracking responses and visual acuity were strikingly different 51 
• The three strains were differentially susceptible to experimental RGC death 52 
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Abbreviations 53 
CTB  cholera toxin subunit β 54 
dLGN  dorsal lateral geniculate nucleus 55 
dpi  days post injury/injection 56 
IOP  intraocular pressure 57 
L-Dopa L-3,4-dihydroxyphenylalanine 58 
LP  laser photocoagulation 59 
NMDA N-methyl-D-aspartic acid 60 
ONC  optic nerve crush 61 
PBS  phosphate-buffered saline 62 
PFA  paraformaldehyde 63 
rd1  retinal degeneration 1 mutation 64 
RGC  retinal ganglion cell 65 
ROI  region of interest 66 
(SD-)OCT (spectral domain-) optical coherence tomography 67 
(s)SC  (superficial layers of the) superior colliculus 68 
TBS  tris-buffered saline 69 
Tyr  Tyrosinase gene 70 
VGluT2 vesicular glutamate transporter 2 71 
72 
1. Introduction 73 
Glaucoma is a heterogeneous group of disorders that have in common the progressive death 74 
of retinal ganglion cells (RGCs) and degeneration of the optic nerve. Worldwide, over 60 75 
million people are believed to be at risk to become irreversible blind, due to this 76 
neurodegenerative disease (Quigley and Broman, 2006; Tham et al., 2014). Although 77 
elevated intraocular pressure (IOP) is considered the major risk factor –and sole target for 78 
clinical treatment– glaucoma etiology is still not completely understood and thought to 79 
involve a dynamic interplay of genetic predisposition and age-related and environmental 80 
stressors (Calkins, 2012; Calkins and Horner, 2012; Leske et al., 2007; Nickells, 2007). This 81 
complexity and multifactorial nature of glaucoma is challenging scientists and clinicians to 82 
understand the underlying mechanisms leading to neurodegeneration and to find novel 83 
therapeutic approaches to fight this blinding disease. Mouse disease models have proven 84 
indispensable in this quest, yet the complexity of the vast number of models and mouse 85 
strains has also led to confusing findings. 86 
Previous papers reported that CD1- mice are more susceptible to ocular hypertension-induced 87 
glaucoma as compared to C57Bl/6 mice (Cone et al., 2010; Cone et al., 2012; Nguyen et al., 88 
2013). This greater susceptibility could derive from structural differences in the eye/visual 89 
system of either mouse strain or from a differential response to elevated IOP. The assess 90 
whether albinism alone is the main factor predisposing CD-1 mice to more severe 91 
glaucomatous neurodegeneration, we tested CD-1, albino C57Bl/6 and pigmented C57Bl/6 92 
mice in a model for ocular hypertension-induced glaucoma and two other optic neuropathy 93 
models (i.e. intravitreal N-methyl-D-aspartic acid (NMDA) injection and optic nerve crush 94 
(ONC)). 95 
Whether or not related to albinism, many morphological and functional characteristic of the 96 
eye have been shown to vary among mouse strains, including IOP (Cone et al., 2012; John et 97 
al., 1997; Savinova et al., 2001), aqueous humor outflow resistance (Boussommier-Calleja 98 
and Overby, 2013), scleral biomechanics (Nguyen et al., 2013), RGC and cone density 99 
(Salinas-Navarro et al., 2009b; Whitney et al., 2011; Williams et al., 1996), congenital retinal 100 
degeneration (Chang et al., 2013; Clapcote et al., 2005; Mattapallil et al., 2012; Serfilippi et 101 
al., 2004; Wong and Brown, 2006), susceptibility to photoreceptor death (Matsumoto et al., 102 
2014), visual projection patterns (Drager and Olsen, 1980; Rebsam et al., 2012; Rice et al., 103 
1995), and performance in vision-guided behavior tasks (Balkema and Drager, 1991; Wong 104 
and Brown, 2006). We therefore first investigated the baseline phenotype of the retina and 105 
retinofugal projection in the three wild type mouse strains mentioned above, looking for traits 106 
that might relate to the differential glaucoma susceptibility. 107 
 108 
2. Methodology 109 
2.1. Experimental animals 110 
Three mouse strains/stocks1 were used in this study: C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice. 111 
The CD-1 and C57Bl/6-Tyrc mouse strains both carry a homozygous Cys103Ser mutation 112 
(designated Tyrc) in the tyrosinase (Tyr) gene, resulting in oculocutaneous albinism 113 
(Beermann et al., 2004; Lavado and Montoliu, 2006). Although C57Bl/6-Tyrc and CD-1 are 114 
both albino mice, they have a very distinct genetic background: while C57Bl/6-Tyrc inbred 115 
mice share the same genetic background as the C57Bl/6 strain, CD-1 mice are an outbred 116 
strain, implying high genetic heterogeneity (Chia et al., 2005). 117 
All studies were conducted in compliance with the European Communities Council Directive 118 
of 22 September 2010 (2010/63/EU) and the Belgian legislation (KB of 29 May 2013), and 119 
                                                 
 
1 Outbred colonies are usually referred to as ‘stocks’, whereas inbred ones are referred to as ‘strains’ or ‘lines’. 
However, to facilitate reading we will refer to all of them as ‘strains’. 
were approved by the KU Leuven institutional ethical committee. Adult (2-4 months) 120 
C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice were obtained from the university breeding colony. 121 
Animals were kept under a 12/12 light-dark cycle and had ad libitum access to food and 122 
water. 123 
 124 
2.2. Genotyping 125 
Mice were genotyped for the retinal degeneration 1 (rd1) mutation of the Pde6b gene. 126 
Briefly, DNA was extracted from tail biopsies, and genotyping PCR was performed with the 127 
Fast Hotstart Genotyping PCR kit (Kapa Biosystems), in 30 cycles at the following 128 
temperatures: denaturation at 94°C for 30 seconds, annealing at 55°C for 30 seconds, and 129 
polymerization at 72°C for 30 seconds. The amplified DNA products were analyzed by 130 
electrophoresis on a 2% agarose gel. The following primer sequences were used, producing 131 
237 bp and 562 bp bands for wild type and rd1 genotypes, respectively: 132 
5’ ACCTGCATGTGAACCCAGTATTCTATC 3’ (Pde6b1); 133 
5’ CTACAGCCCCTCTCCAAGGTTTATAG 3’ (Pde6b2); 134 
5’ AAGCTAGCTGCAGTAACGCCATTT 3’ (Pde6b3). 135 
 136 
2.3. Intra-ocular pressure measurement 137 
The IOP was measured in awake animals with a calibrated rebound tonometer (Tono-Lab, 138 
iCare) (Haddadin et al., 2009; Haddadin et al., 2012). IOP was measured before LP (day 0) 139 
and on day 1 till 7 following LP. In short, the mouse was hold with one hand by loosely 140 
grabbing the fur in the neck and care was taken to avoid stress and pressure on the neck 141 
region. Next, 10 independent IOP measurements were taken per eye, from which the highest 142 
two and lowest two values are excluded in order to reduce variability. An average IOP for 143 
each eye was calculated from the remaining six values. IOP measurements were always 144 
performed in the morning, to avoid potential variability due to diurnal IOP variations. The 145 
untreated, contralateral eye was used as a control. 146 
 147 
2.4. Spectral domain optical coherence tomography  148 
Thickness of the retinal layers was evaluated using a spectral domain optical coherence 149 
tomography (SD-OCT) system (Envisu R2210, Bioptigen) (Buys et al., 2013). Upon general 150 
anesthesia (i.p. 75 mg/kg body weight ketamine, Anesketin, Eurovet; i.p. 1 mg/kg 151 
medetomidine, Domitor, Pfizer), pupils were dilated by topical application of 0.5% 152 
tropicamide (0.5% Tropicol, Thea). SD-OCT was performed using 100 consecutive B-scan 153 
lines composed of 1000 A-scans, in a 1.4x1.4mm field. After the procedure, anesthesia was 154 
reversed by means of atipamezol (i.p. 1 mg/kg, Antisedan, Pfizer) and antibiotic ointment 155 
was applied to the eye (tobramycin 3 mg/g, Tobrex, Alcon). Total retinal thickness and 156 
thickness of different retinal layers were analyzed using InVivoVue Diver 2.2 software 157 
(Bioptigen). 158 
 159 
2.5. Optokinetic tracking response 160 
The optokinetic tracking response was measured under photopic conditions in a virtual-161 
reality chamber (OptoMotry, Cerebral Mechanics), as described by Prusky et al. (Douglas et 162 
al., 2005; Prusky et al., 2004). Briefly, a virtual cylinder comprised of a vertical sine wave 163 
grating was projected on four computer screens facing into a box.  The animal was placed on 164 
a platform in the center of the arena and a video camera, situated above the animal, provided 165 
real-time video feedback. Visual acuity was measured using a staircase procedure, in which 166 
different spatial frequencies (100% contrast, 12° per second speed) varied randomly and 167 
separate for each eye. The experimenter judged whether the mouse displayed optokinetic 168 
tracking, and the maximum spatial frequency at which optokinetic tracking seen, was 169 
determined. 170 
 171 
2.6. Surgical procedures 172 
All surgical procedures were performed under general anesthesia with ketamine and domitor 173 
(see above). After the procedure, anesthesia was reversed by means of atipamezol (see 174 
above), and antibiotic ointment (see above) was applied to avoid corneal desiccation and 175 
infection of the eye. Untreated eyes from a separate cohort of untreated animals served as 176 
controls. 177 
2.6.1. Intravitreal injections 178 
Intravitreal injections were performed as described (Lebrun-Julien et al., 2009), to deliver 179 
either anterograde tracer or NMDA. Briefly, a total volume of 2 µl (0.5 µl/second) was 180 
injected into the superior quadrant of the right eye using a glass capillary with a 50-70 µm 181 
outer diameter, connected to a Hamilton syringe. In addition to general anesthesia, eye drops 182 
with topical anesthesia (oxybuprocaine 0.4%, Unicaïne, Thea) were given. For anterograde 183 
tracing of the dorsal lateral geniculate nucleus (dLGN) and the superior colliculus (SC), 184 
Alexa Fluor-488-conjugated cholera toxin β subunit (CTB) (0.5% in phosphate-buffered 185 
saline (PBS) containing 0.5% DMSO; Life Technologies) was injected in the right eye, and 186 
mice were sacrificed at 7 dpi. In order to induce retinal excitotoxicity, NMDA (7.5 mM, in 187 
PBS; Sigma-Aldrich) was injected, and animals were sacrificed at 4 days post injection (dpi). 188 
2.6.2. Optic nerve crush 189 
Intraorbital ONC was performed as described (Parrilla-Reverter et al., 2009). Briefly, an 190 
incision was made in the skin overlying the superior orbital rim, the supero-external orbital 191 
contents were dissected, and the superior and external rectus muscles were transected. The 192 
exposed optic nerve was then crushed 1 mm from the globe with a watchmaker’s forceps for 193 
10 seconds. Funduscopy was performed before and after the procedure to assess retinal 194 
perfusion. Animals were sacrificed at 7 days post injury (dpi). 195 
2.6.3. Laser photocoagulation (LP) 196 
Tropicamide eye drops (1% Mydriacyl, Alcon) were administered to ensure pupil dilatation. 197 
Next, monocular hypertension in the left eye was induced via LP of the episcleral and 198 
perilimbal vessels, as described (Salinas-Navarro et al., 2009a; Valiente-Soriano et al., 2015). 199 
Briefly, a 532 nm diode laser (Vitra, Quantel Medical) was used to deliver a number of laser 200 
burns in one single session. The number of spots, power, and duration of the laser pulse were 201 
adjusted according to the mouse strain. For C57Bl/6 mice, the vessels were photocauterized 202 
with 140 spots, with a laser power and duration of 100 mW and 0.05 seconds, respectively. 203 
For C57Bl/6-Tyrc mice, the vessels were photocauterized with 100 spots, with a laser power 204 
and duration of 200 mW and 0.5 seconds, respectively. For CD-1 mice, the vessels were 205 
photocauterized with 70 spots, with a laser power and duration of 300 mW and 0.5 seconds, 206 
respectively. Animals were sacrificed at 14 dpi. 207 
2.6.4. Retrograde labeling from the superior colliculus 208 
To identify the population of RGCs with functional retrograde axonal transport in the ocular 209 
hypertension model, hydroxystilbamidine methanesulfonate (OHSt) (Life Technologies) was 210 
applied to both SC (Galindo-Romero et al., 2013; Salinas-Navarro et al., 2009b). In brief, 211 
after exposing the midbrain, a small pledge of gelatin sponge (Espongostan, Ferrosan) soaked 212 
in saline containing 10% OHSt and 10% DMSO, was applied over the entire surface of both 213 
SC following previously described methods (Salinas-Navarro et al., 2009). Retinas were 214 
dissected 4 days post LP, and subsequently immunostained for Brn3a (see below). Mosaic z-215 
stack images of the entire retina were taken with a confocal microscope (FV1000, Olympus), 216 
equipped with FluoViewer 4.0 software (Olympus). 217 
 218 
2.7. Hematoxylin and eosin staining 219 
Mice were deeply anaesthetized (i.p. 30 mg/kg sodium pentobarbital, Nembutal, Ceva), 220 
perfused transcardially with 1% phosphate-buffered paraformaldehyde (PFA) and eyes were 221 
dissected. Eyes were fixed overnight in 1% PFA, processed for paraffin-embedding and 222 
transverse sections (10 µm) of the whole eye were made. Sections were first deparaffinized 223 
and rehydrated, followed by a histological staining with hematoxylin (Sigma) and 1% eosin 224 
(Prosan). Next, sections were dehydrated and mounted using DPX neutral mountant (Prosan). 225 
Images were taken with a light microscope (Zeiss Axio Imager Z.1), equipped with an 226 
AxioCam MRm camera and ZEN software (Zeiss). 227 
 228 
2.8. Immunohistochemistry 229 
In order to quantify retinal ganglion cell density, a Brna3 immunostaining was performed on 230 
retinal flatmounts (Galindo-Romero et al., 2011; Nadal-Nicolas et al., 2009). Mice were 231 
deeply anaesthetized with sodium pentobarbital (see above) and sacrificed by cervical 232 
dislocation. Eyes were dissected and fixed for 1 hour in 4% PFA. Next, retinas were 233 
flatmounted and again fixed for 1 hour in 4% PFA. Flatmounted retinas were frozen for 15 234 
minutes at -80°C, before applying the primary antibody goat anti-Brn3a (Santa Cruz, C-20, 235 
sc-31984) (1:750), which was diluted in PBS containing 2% Triton X-100 and 2% rabbit pre-236 
immune serum. The next day, Alexa Fluor-488-conjugated rabbit anti-goat IgG antibody 237 
(Life Technologies) (1:500) was applied for 2 hours. Retinal flatmounts were rinsed with 238 
PBS with 0.5% Triton X-100 in between steps, and mounted using mowiol mounting medium 239 
(10% mowiol 4-88 (Sigma-Aldrich), 40% glycerol, 0.1% 1,4-diazabicyclo-[2,2,2]-octane in 240 
0.2 M Tris-HCl [pH 8.5]). Mosaic z-stack images of the entire retina were taken with a 241 
multiphoton microscope (BX61WI, Olympus), equipped with a MaiTai HP DeepSee laser 242 
(690-1020 nm, Spectra Physics) and FluoViewer 4.0 software (Olympus). 243 
In order to delineate dLGN boundaries and SC stratification, an immunostaining for vesicular 244 
glutamate transporter 2 (VGluT2), a discrete marker for presynaptic glutamatergic terminals, 245 
was performed (Dekeyster et al., 2015a; Fujiyama et al., 2003). Mice were deeply 246 
anesthetized with sodium pentobarbital (see above) and perfused transcardially with 4% PFA. 247 
Brains were dissected and post-fixed overnight in 4% PFA. Vibratome sections (50 µm) of 248 
the dLGN and SC brain regions, between Bregma -1.70 mm and -4.84 mm, were mounted on 249 
gelatin-coated microscopy slides and dried overnight at 37°C. After rehydration, sections 250 
were incubated in PaxD permeabilization buffer (PBS with 5 % bovine serum albumin, 0.3% 251 
Triton X-100, and 0.3% sodium deoxycholate) and blocking solution (0.01 M Tris-buffered 252 
saline (TBS) with 0.5% blocking reagent (Perkin-Elmer) and 20% normal donkey serum 253 
(Life technologies)). Next, sections were incubated overnight with rabbit anti-VGluT2 (Life 254 
Technologies, 42-7800) (1:300), diluted in PBS containing 0.3% Triton X-100 and 10% 255 
normal donkey serum. The next day, Alexa Fluor-647-conjugated donkey anti-rabbit IgG 256 
antibody (Life Technologies) (1:200) was applied for 2 hours. Sections were rinsed with 257 
PaxD in between steps, and cover slipped using mowiol mounting medium (see above). 4',6-258 
diamidino-2-phenylindole (1 μg/ml in PBS, Applichem) was used as a fluorescent nuclear 259 
counterstaining. Images were taken with an inverted confocal microscope (FV1000, 260 
Olympus) and were processed with FluoViewer 4.0 (Olympus) and Photoshop CS5 (Adobe) 261 
software. 262 
 263 
2.9. Morphometric analyses and quantification of RGC density 264 
Total retinal thickness, as well as thickness of the different retinal layers, was measured on 6 265 
retinal sections per eye, using Fiji software (Schindelin et al., 2012). For each section, 266 
measurements were performed at two locations in the peripheral retina and two locations in 267 
the central retina.  268 
RGC density was evaluated on entire retinal flatmounts after immunostaining for Brn3a. 269 
RGC density (number of RGCs/mm²) was semi-automatically computed using Fiji software 270 
and an in-house made macro (Geeraerts et al., 2015). Briefly, the mosaic picture of a full 271 
Brn3a-stained retinal flatmount was subjected to a series of operations, consisting of noise 272 
removal via Fiji's ‘Remove Outlier’ plugin, enhancement of the Brn3a+ signal of RGCs via 273 
the determinant of the Hessian, and counting of the resulting local maxima as RGCs. Next, 274 
the retinal flatmount was outlined, and its total area, total number of RGCs and average RGC 275 
density were calculated. 276 
The number of retrogradely labeled RGCs was manually counted after tracing with OHSt 277 
using the “cell counter” plugin of Fiji software. OHSt+ RGCs were quantified in 278 
twelve 250x250 µm frames per retina, by two independent, blinded observers. 279 
 RGC axon terminals, labeled via CTB tracing, were quantified using Fiji software. For the 280 
dLGN, four regions of interest (ROI) were outlined: three ROIs in the contralateral dLGN (in 281 
respect to CTB-injected eye) and one ROI in the ipsilateral dLGN. A schematic overview of 282 
these ROIs, further referred to as ‘contralateral’, ‘contra patch’, ‘contra in ipsi region’, and 283 
‘ipsilateral’, is depicted in Figure 2c. The ROIs ‘contralateral’, ‘contra in ipsi region’, and 284 
‘ipsilateral’ were analyzed on three 100 μm-spaced coronal sections per animal within the 285 
rostrocaudal region between Bregma -2.10 mm and -2.60 mm. The ROI ‘contra patch’ was 286 
analyzed on all sections from Bregma -2.40 mm till -2.80 mm showing this feature. 287 
Immunofluorescence intensity (per µm²) was analyzed in randomly placed frames (50 µm 288 
diameter) in these ROIs and, after background subtraction, a mean value was calculated per 289 
mouse. For the SC, CTB tracing was analyzed qualitatively on sections between Bregma -3.16 290 
mm and -4.84 mm. The boundary between the visually driven superficial layers of the SC, 291 
including the stratum zonale, stratum griseum superficiale, and stratum opticum, and the 292 
underlying deep SC, was outlined based on a VGluT2 immunostaining. A scheme of the 293 
theoretical contralateral and ipsilateral RGC projection zones in the SC is depicted in Figure 3b. 294 
 295 
2.10. Statistics 296 
Normal distribution was verified using a Kolmogorov–Smirnov test and parallel equal 297 
variance between groups was tested. Outliers were identified and excluded, based on a 298 
Grubbs’ test. Statistical tests are mentioned in the figure captions. Briefly, all baseline 299 
characteristics were either analyzed via a paired Student’s t-test, a one-way ANOVA with 300 
post hoc Turkey's multiple comparisons test, or a two-way ANOVA with post hoc Dunnett's 301 
multiple comparisons test. Differences in experimentally induced RGC death were analyzed 302 
among the different strains using a two-way ANOVA with post hoc Turkey's multiple 303 
comparisons test. IOP profiles after LP were analyzed using a repeated measures two-way 304 
ANOVA with post hoc Dunnett's multiple comparisons test. A probability level (α-level was 305 
set to 0.05) of <0.05 was accepted as statistically significant (*p<0.05, **p<0.01, 306 
***p<0.005). All data are presented as mean ± SEM, unless indicated otherwise. For all 307 
statistical analyses GraphPad Prism 6 (GraphPad Software) was used.  308 
 309 
3. Results 310 
3.1. Evaluation of baseline characteristics of three commonly used mouse strains in 311 
glaucoma research 312 
3.1.1. Ocular phenotype 313 
As elevated IOP has been identified as one of the major risk factors for glaucoma, we first 314 
evaluated baseline IOP in the three mouse strains under study. A significant difference in IOP 315 
was seen between C57Bl/6 and CD-1 mice, which had an IOP of 14.2 ± 0.1 mmHg and 13.2 316 
± 0.1 mmHg, respectively (p<0.0001). C57Bl/6-Tyrc mice displayed an even higher IOP, 317 
which –with a value of 16,6 ± 0.2 mmHg–t was 2.4 mmHg and 3.4 mmHg higher than the 318 
IOP of C57Bl/6 and CD-1 mice, respectively (p<0.001).  319 
Next, we evaluated retinal histology via in vivo OCT imaging (Figure 1a-d) and on 320 
hematoxylin and eosin-stained retinal cross-sections (Figure 1e-h). No significant differences 321 
in the thickness of any individual retinal layer, and no signs of neurodegeneration were seen 322 
(Figure 1i). In addition, RGC density was quantified on retinal flatmounts, revealing a small 323 
yet significant, biological variation. Despite their elevated IOP, C57Bl/6-Tyrc mice showed a 324 
similar RGC density as C57Bl/6 mice, which share an identical genetic background. CD-1 325 
mice, on the other hand, exhibited significantly higher RGC densities than C57Bl/6 and 326 
C57Bl/6-Tyrc mice (+28.5% and +22.4%, respectively) (p<0.0001) (Figure 1j). A similar 327 
accordance was seen for the total RGC counts in these strains (data not shown). 328 
Overall, the histological architecture of the three strains in this study is highly similar. Small, 329 
biological variations do exists, yet seem to be unrelated to developmental or 330 
neurodegenerative differences. 331 
Importantly, OCT imaging and histological analysis sporadically revealed severe retinal 332 
dystrophy in CD-1 mice: the outer plexiform layer, outer nuclear layer, and photoreceptor 333 
layer were completely absent in a subset of these animals (Figure 1d, h). A large-scale 334 
genotyping experiment (N=106) confirmed that 21% of the mice in our CD-1 colony were 335 
homozygous for the rd1 mutation of the Pde6b gene, leading to photoreceptor degeneration. 336 
These mice were excluded from the study. 337 
 338 
3.1.2. Retinofugal projections 339 
Retinofugal projections to the two major subcortical relay stations, the dLGN and SC, were 340 
studied after anterograde tracing with fluorescently labeled CTB (Figure 2c). Analysis of the 341 
CTB signal (fluorescence intensity/µm²) on coronal brain sections, unveiled prominent 342 
differences in the patterns of RGC synapses in the dLGN and SC of C57Bl/6, C57Bl/6- Tyrc, 343 
and CD-1 mice.  344 
In the dLGN, ipsilateral projections from the CTB-injected eye (ROI ‘ipsilateral’) appeared 345 
more diffuse in C57Bl/6- Tyrc and CD-1 mice, as compared to C57Bl/6 mice ([y] p<0.05) 346 
(Figure 2a, b). In addition, when looking at the contralateral dLGN, the area with ipsilateral 347 
termini was not devoid of CTB signal (ROI ‘contra in ipsi region’) in C57Bl/6-Tyrc and CD-1 348 
mice: a black hole in the CTB+ contralateral dLGN signal is seen in C57Bl/6 mice, but not in 349 
the albino mice ([z] p<0.001 versus C57Bl/6-Tyrc, p<0.01 versus CD-1) (Figure 2a (arrow), 350 
b). Moreover, in C57Bl/6 animals, the density of RGC synapses did not differ between the 351 
contralateral zone of the contralateral dLGN (ROI ‘contralateral’) and the ipsilateral zone of 352 
the ipsilateral dLGN (ROI ‘ipsilateral’). However, in C57Bl/6-Tyrc and CD-1 mice, 353 
ipsilateral projections showed lower fluorescence intensity/μm² values versus contralateral 354 
projections (ROI ‘ipsilateral’ versus ROI ‘contralateral’) ([x] p<0.05 for C57Bl/6-Tyrc, 355 
p<0.001 for CD-1) (Figure 2a, b). 356 
Finally, a cluster of contralaterally projecting axon terminals that appeared separated from the 357 
other contralateral projections (ROI ‘contra patch’) was found in the contralateral, caudal 358 
dLGN, adjacent to the optic tract (Figure 2d). Interestingly, this phenomenon was only 359 
sporadically observed in CD-1 mice, in which it spanned a distance of less than 200 µm, 360 
while it was seen in all C57Bl/6-Tyrc mice in this study, spanning a distance of approximately 361 
500 μm along the rostrocaudal axis. Quantification of the CTB signal in this ROI ‘contra 362 
patch’ in the C57Bl/6-Tyrc strain, showed that RGC axon termini were more dense as 363 
compared to the adjacent contralateral zone (ROI ‘contra’) (p<0.05) (Figure 2e). 364 
In summary, these results confirm a less strict segregation of ipsilateral and contralateral 365 
projections to the dLGN, and reduced – or at least more diffuse –, ipsilateral projections in 366 
C57Bl/6-Tyrc and CD-1 albino animals, compared to the C57Bl/6 strain. Moreover, a spatial 367 
segregation of densely packed contralateral RGC terminals was described in the caudal 368 
dLGN of C57Bl/6-Tyrc, and to a lesser extent CD-1, mice. 369 
In the SC, in all three mouse strains, contralateral RGCs terminated in the superficial layers 370 
of the SC (sSC), including the stratum zonale, stratum griseum superficiale, and stratum 371 
opticum, and no apparent changes were noted in this dominant projection zone. In contrast, 372 
differential segregation of the ipsilateral RGC axons to the lower stratum opticum was seen 373 
(Figure 3a, b). In the rostral sSC, these ipsilateral projections were packed in a series of 374 
delineated patches along the lateromedial axis (Figure 3a, cross-section 1). Similar to the 375 
dLGN, ipsilateral projections to the SC were less dense and more diffuse in C57Bl/6-Tyrc and 376 
CD-1 mice, compared to C57Bl/6 animals, and seemingly interconnected (Figure 3a, cross-377 
section 1). More caudal along the rostrocaudal axis, the ipsilateral RGC axons bundled in a 378 
tube running parallel to the brain midline (Figure 3a, cross-sections 2 and 3). In CD-1 mice, 379 
this rostrocaudal tube appeared somewhat stretched along the lateromedial axis, rather than 380 
being round, as was seen in the C57Bl/6 mice (Figure 3a, cross-section 3 (arrow)). Of note, 381 
these disparities of the retinocollicular projections were most pronounced when comparing 382 
C57Bl/6 with CD-1. The organization of the retinocollicular ipsilateral projections in 383 
C57Bl/6-Tyrc mice appeared to be somewhat in between the C57Bl/6 and CD-1 phenotypes, 384 
with rostral patches being more delineated as compared to CD-1 mice, yet less dense as 385 
compared to C57Bl/6. Furthermore, the rostrocaudal tube appeared less delineated and 386 
slightly larger as compared to C57Bl/6 strain, but not as stretched as seen in the CD-1 mice. 387 
Strikingly, all C57Bl/6 and C57Bl/6- Tyrc mice displayed a small, densely labeled patch of 388 
ipsilaterally projecting RGC axons terminating in the medial stratum zonale (Figure 3a, 389 
cross-section 1 (arrowhead)), which was only visible over a rostrocaudal distance of less than 390 
200 µm. This was never observed in CD-1 animals and might therefore be linked to the 391 
C57Bl/6 genetic background. Of note, the strain-related differences in the visual projection to 392 
the SC shown in this study relate to the ipsilateral projection zones, which make up only 1 to 393 
3% of the SC. Anterograde/retrograde axonal tracing to/from the SC therefore remains a 394 
legitimate ways of assessing axonal transport differences in these strains (see below). 395 
Taken together, as with the retinogeniculate projections, ipsilateral projections to the SC were 396 
more diffuse in C57Bl/6-Tyrc and CD-1 albino animals, compared to the C57Bl/6 strain. 397 
Moreover, their segregation pattern seemed to be affected as well, with interconnected 398 
patches of ipsilateral termini in the stratum opticum, and a deformation of the rostrocaudal 399 
tube of ipsilateral axons. Finally, in the C57Bl/6 genetic background, a densely labeled patch 400 
of ipsilateral RGC termini was seen in the medial stratum zonale. Importantly, while these 401 
strain differences seem to be confined to the ‘subordinate’ – in comparison to the dominant, 402 
contralateral projections to the sSC – ipsilateral projection areas in the SC, behavioral 403 
analyses suggest that they may have major implications on SC function (see below). 404 
 405 
3.1.3. Optokinetic tracking response 406 
In addition to the morphological study of the retinofugal projections to the dLGN and SC, the 407 
retinocollicular circuit was also evaluated by means of a functional test, i.e. the optokinetic 408 
tracking response. Visual acuity, measured as the highest spatial frequency (cycles/degree) 409 
eliciting an optokinetic response, was found to be divergent among the C57Bl/6, C57Bl/6- 410 
Tyrc, and CD-1 mouse strains (p<0.0001 for ANOVA). C57Bl/6 mice displayed normal 411 
visual acuity (0.40 ± 0.004 c/d) (Figure 3c), conform to what has been reported for this strain 412 
(Prusky et al., 2004), yet the optokinetic tracking response in C57Bl/6-Tyrc and CD-1 mice 413 
was severely affected. Strikingly, normal tracking reflexes were almost completely absent in 414 
these albino mice, rather they displayed counter-directive head movements. As this behavior 415 
clearly consisted of reflexive movements in response to the moving gratings, we decided to 416 
catalog them as true responses and to determine visual acuity based on these optokinetic 417 
‘anti-tracking’ responses. Still, in comparison to C57Bl/6 mice, reduced and more variable 418 
visual acuities of 0.32 ± 0.01 c/d and 0.28 ± 0.01 c/d were found for C57Bl/6-Tyrc (p<0.001) 419 
and CD-1 mice (p<0.001), respectively (Figure 3c). 420 
To summarize, assessment of the optokinetic tracking response revealed that vision is 421 
preserved in all three mouse strains. Nevertheless, visual acuity is lower in albino mice as 422 
compared to the C57Bl/6 mice, and their optokinetic tracking behavior is severely disturbed. 423 
Of note, the latter might potentially relate to the differential segregation of ipsilateral 424 
projections to the SC seen in these albino strains. 425 
 426 
3.2. Evaluation of the three most commonly used glaucoma models in C57Bl/6, C57Bl/6-427 
Tyrc, and CD-1 mice 428 
In a second part of this study, we evaluated differences in the success and applicability of 429 
three commonly used glaucoma models in C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice. In 430 
addition, we also evaluated the susceptibility of each of the three mouse strains to these 431 
disease models. Importantly, given the complexity of the disease, there is still no ideal animal 432 
model that mimics all aspects of glaucoma pathogenesis. Nonetheless, a variety of different 433 
models does exist, each with their strengths and limitations, which allow to investigate at 434 
least defined processes contributing to glaucomatous damage.  435 
The first optic neuropathy model tested, consisted of an intravitreal injection of the glutamate 436 
analogue NMDA. The importance of this excitotoxic model is often somewhat underscored, 437 
due to the controversy about excitotoxicity as a contributing factor to glaucoma. 438 
Nevertheless, it is a valuable model to investigate neuroprotective strategies to treat 439 
secondary RGC loss and excitotoxic insults in the central nervous system (CNS) (Almasieh et 440 
al., 2012; Casson, 2006; Kalia et al., 2008; Tilleux and Hermans, 2007). Intravitreal injection 441 
of NMDA had a nearly 100% success rate in inducing RGC death, although a moderate 442 
degree of variability existed. Intriguingly, intravitreal injection of NMDA in the three mouse 443 
strains resulted in very divergent degrees of RGC degeneration (p<0.001 for ANOVA). 444 
Evaluation of RGC survival at 4 dpi, proved C57Bl/6 mice to be the most resistant to 445 
NMDA-induced RGC death, while CD-1 mice were the most sensitive (Figure 4a).  446 
Next, we evaluated the effect of ONC on RGC survival in C57Bl/6, C57Bl/6-Tyrc, and CD-1 447 
mice. Although the acuteness of this model does not correspond to human glaucoma patients, 448 
at least part of the glaucomatous damage in patients with ocular hypertension is believed to 449 
result from IOP-induced mechanical forces damaging the optic nerve axons. As such, the 450 
ONC model is of particular benefit when studying the contribution of axonal damage to 451 
glaucoma pathogenesis (Johnson and Tomarev, 2010; McKinnon et al., 2009). Evaluation of 452 
RGC survival at 7 dpi revealed that C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice responded 453 
identically to ONC, resulting in highly reproducible, low-variability results among the three 454 
strains under study (Figure 4b). 455 
Finally, RGC degeneration following LP-induced monocular hypertension was investigated. 456 
Given that elevated IOP remains the most important modifiable risk factor for glaucoma, 457 
animal models of OHT are highly valued in the elucidation of the pathology of RGC 458 
degeneration in humans (Vidal-Sanz et al., 2012). Monocular hypertension models have been 459 
extensively described in CD-1 mice (Cuenca et al., 2010; Dekeyster et al., 2015a; Fu and 460 
Sretavan, 2010; Salinas-Navarro et al., 2009a). Due to pigmentation of the sclera, ciliary 461 
body, and iris, as well as strain-related differences in the size of the eye, however, the laser 462 
settings used for CD-1 mice are insufficient to induce monocular hypertension in C57Bl/6 463 
and C57Bl/6-Tyrc mice. Therefore, laser settings were optimized to yield an optimal set of 464 
parameters for each of the three mouse strains (own observations, (Valiente-Soriano et al., 465 
2015)). These settings resulted in an IOP profile that mimics the well-established response in 466 
CD-1 mice, with a success rate of nearly 100% in all three strains. More in detail, a steep rise 467 
in IOP was seen at 1 day post LP, resulting in an average IOP of 41.9 ± 1.6 mmHg. In 468 
general, this IOP elevation was sustained for 5 days (4 days for C57Bl/6-Tyrc mice) 469 
(p<0.001), after which the IOP gradually decreased to return to its baseline value by day 6 470 
(Figure 4c). 471 
At 14 dpi, a sectorial pattern of RGC death, in addition to diffuse loss of RGCs, was observed 472 
in all three mouse strains under study. However, notwithstanding the overlap in IOP profiles, 473 
the extent of RGC degeneration following LP-induced temporary monocular hypertension did 474 
vary. While no significant difference in average RGC death was observed between C57Bl/6 475 
and C57Bl/6-Tyrc mice (26,0 ± 3.8% versus 41.0 ± 10.0%), RGC death was significantly 476 
higher in CD-1 mice (86.9 ± 2.1%) as compared to the C57Bl/6 background (p<0.0001) 477 
(Figure 4d). A correlation analysis for each strain, plotting individual IOP exposure (X, i.e. 478 
integral ΔIOP) and RGC loss (Y) for each animal, revealed that the observed intra-strain 479 
variation in RGC loss is unrelated to IOP for CD-1 (Pearson R = -0.3429; p>0.05) and 480 
C57Bl/6-Tyrc (Pearson R = -0.4957; p>0.05), but not for C57Bl/6 mice (Pearson R =  481 
-0.8524; p<0.01). Overall, as no correlation between RGC survival and IOP exposure was 482 
found for two out of the three strains, these results confirm that the inter-strain differences in 483 
RGC death that were observed in this study reflect the effect of ‘strain-related’ factor(s) 484 
rather than IOP differences. 485 
 Intriguingly, the effect of the genetic background on RGC survival within the ocular 486 
hypertension model, was also apparent when axonal transport integrity and visual function 487 
were evaluated. At 4 dpi, all RGCs were still alive, yet the earliest signs of dysfunctional 488 
axonal transport became apparent, similar to what has been reported previously (Salinas-489 
Navarro et al., 2009a; Valiente-Soriano et al., 2015; Vidal-Sanz et al., 2012) (Figure 5). 490 
Indeed, the number of retrogradely labeled RGCs was immediately lower in CD-1 mice as 491 
compared to mice with a C57Bl/6 background (p<0.001 versus C57Bl/6, p<0.05 versus 492 
C57Bl/6-Tyrc) (Figure 5b). Also the rate of visual acuity deterioration was faster in CD-1 493 
mice (p<0.001 for ANOVA) (Figure 5d), indicative for a higher susceptibility of the RGCs 494 
and their axons to ocular hypertension-induced neurodegeneration. 495 
Overall, genetic background appeared to have a clear impact on RGC degeneration, although 496 
this was very much depending on the kind of glaucoma disease models used. While RGC 497 
degeneration resulting from ONC proved to be equal in the three mouse strains studied, 498 
NMDA- and ocular hypertension-induced RGC death were dramatically modulated by the 499 
genetic background. Notably, in both models, CD-1 mice appeared to display the highest 500 
sensitivity, while the C57Bl/6 background was the most resistant to RGC damage.  501 
 502 
4. Discussion 503 
In this study, we set out to discover whether differential susceptibility to glaucomatous RGC 504 
degeneration in CD-1, albino C57Bl/6 and pigmented C57Bl/6 mice, is related to structural 505 
differences in the eye/visual system of either mouse strain, to a differential response to 506 
elevated IOP, and/or to other not-yet-known factors. A central question in this investigation 507 
was whether albinism alone is the main factor predisposing mice to more severe 508 
glaucomatous neurodegeneration, or whether other factors inherent to the genetic background 509 
are at play as well. 510 
 511 
4.1. Differential ocular morphology and visual system organization in pigmented versus 512 
albino mice 513 
No fewer than 30.000 genes are believed being expressed in the mammalian nervous system, 514 
and it is to be suspected that a small yet important subset of alleles of this extraordinarily 515 
large number of genes has well-defined effects on the structure and function of the 516 
mammalian CNS (Williams et al., 1996). In the eye/retina, many morphological and 517 
functional characteristic have been shown to vary among mouse strains: IOP and aqueous 518 
humor outflow resistance, scleral biomechanics, RGC and cone density, congenital retinal 519 
degeneration, visual projection patterns, performance in vision-guided behavior tasks, etc. 520 
(see introduction). In a first step of this investigation, we set out by defining to what extent 521 
albinism (i.e. the Tyrc mutation) contributes to these baseline characteristics – that might 522 
ultimately influence the response to glaucomatous injury. Unraveling this research question, 523 
we took advantage of the genetic lineage of C57Bl/6 and C57Bl/6-Tyrc mice, which share the 524 
exact same genetic background except for one mutation in the Tyrc gene. Besides, CD-1 mice 525 
were included as a third strain, sharing the Tyrc mutation with the C57Bl/6-Tyrc mice yet 526 
further belonging to a very distinct genetic background. As such, the combinatorial study of 527 
these three mouse strains allowed us to dissect the relative importance of albinism versus 528 
genetic background. 529 
Given the crucial role of L-3,4-dihydroxyphenylalanine (L-Dopa) during the development of 530 
the iridocorneal angle and retinofugal projections (Bhansali et al., 2014; Cronin et al., 2003; 531 
Eisenhofer et al., 2003; Gimenez et al., 2004; Jeffery et al., 1997; Jeffery et al., 1994; Libby 532 
et al., 2003; Roffler-Tarlov et al., 2013; Savinova et al., 2001), we hypothesized that L-Dopa 533 
depletion in albino mice with the Tyrc mutation – tyrosinase is a rate-limiting in L-Dopa 534 
biosynthesis – would result in ocular hypertension and misguidance of RGC axons at the 535 
optic chiasm. Indeed, significant differences in baseline IOP were observed amongst the three 536 
mouse strains included in this study. However, although a higher IOP was seen in 537 
C57Bl/6-Tyrc mice, confounding genetic factors appear to counteract IOP elevation in CD-1 538 
mice. Second, and in agreement with the hypothesis, missegregation of retinogeniculate 539 
projections came to light in C57Bl/6-Tyrc and CD-1 mice: a reduced density and rather 540 
diffuse appearance of ipsilateral projection zones was seen in the dLGN, and to a lesser 541 
extent also in the SC. Moreover, these disturbed retinotopic visual field representations 542 
appeared to affect visual functioning, as C57Bl/6-Tyrc and CD-1 mice not only had reduced 543 
visual acuity, but also displayed so-called optokinetic ‘anti-tracking’ responses. Of note, this 544 
striking ‘misbehavior’ of albino mice in the optomotor test has never been described before, 545 
and suggests that the full implications of axonal misrouting in the albino visual system are 546 
still being uncovered. The present study furthermore discovered a densely labeled, well-547 
delineated patch of ipsilaterally projecting RGCs in the medial stratum zonale of the SC, in 548 
C57Bl/6 and C57Bl/6-Tyrc mice, but not in CD-1 animals. By consequence, this feature 549 
seems to be related to the C57Bl/6 genetic background, not to tyrosinase deficiency. 550 
Also related to the genetic background rather than directly originating from the Tyrc mutation, 551 
is the variance in RGC numbers in different mouse strains (Williams et al., 1996). Significant 552 
differences, both in the total number and density of the RGC population, were seen between 553 
the C57Bl/6 and the CD-1 genetic background in this study, yet not among C57Bl/6 and 554 
C57Bl/6-Tyrc mice. In contrast, the gross organization of the retina, i.e. the thickness of its 555 
different layers, was similar in C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice. Our data confirm 556 
previous reports (Salinas-Navarro et al., 2009b; Williams et al., 1996) and once more point 557 
out that CD-1 mice carrying a homozygous rd1 mutation of the Pde6b gene – which does not 558 
occur in the C57Bl/6 background – are doubtfully suited for research into ocular pathologies 559 
(Hart et al., 2005; Serfilippi et al., 2004). It is thus advisable for any retina study using this 560 
albino strain, to determine the presence of the mutation and to monitor potential interference 561 
with experimental outcomes. 562 
Altogether, in the visual system, albino mutations in the mouse Tyr gene appear to result in a 563 
set of diverging phenotypes that are the result of differential modifier genes in the genetic 564 
background. While the function of tyrosinase in melanin synthesis results in a phenotype, i.e. 565 
oculocutaneous albinism, that remains unaltered regardless of the genetic background, L-566 
Dopa depletion in these mice leads to a set of developmental abnormalities that are modified 567 
by complex, multifactorial influences of the genetic background. 568 
 569 
4.2. Why are mouse strains differentially susceptible to RGC degeneration induced by 570 
different optic neuropathy models? 571 
In a second aspect of this study, we continued to investigate whether the greater susceptibility 572 
to RGC degeneration that has been reported in CD-1 mice (Cone et al., 2010; Cone et al., 573 
2012; Nguyen et al., 2013), could derive from the aforementioned structural differences in the 574 
eye/visual system, from a differential response to elevated IOP, or from other disease-575 
modifying genes encoded in the genetic background. 576 
Altogether, susceptibility to RGC degeneration is a complex trait modulated by several 577 
distinct genomic loci (Dietz et al., 2008; Li et al., 2007; Templeton et al., 2009). The present 578 
results can be interpreted in the context of a study by Libby et al., who dissected the 579 
multifactorial complexity of genetic susceptibility factors into two broad classes of genes that 580 
can affect the outcome of glaucomatous damage. The first class modulates the intrinsic 581 
susceptibility of RGCs and comprises genes that directly affect RGC survival, including pro-582 
and anti-apoptotic genes, genes encoding free radical scavengers and heat shock proteins, etc. 583 
The second class of genes modulates extrinsic susceptibility of RGCs, e.g. genes predicted to 584 
influence micro- and macroglia reactivity, ECM composition and dynamics, density and 585 
regulation of retinal and optic nerve vasculature, the immune responses in the eye (Li et al., 586 
2007; Libby et al., 2005). 587 
For a start, the experimental outcomes in the NMDA and ONC models of optic neuropathy 588 
are excellent illustrations of this concept of genes modulating the intrinsic versus extrinsic 589 
susceptibility of RGCs to apoptosis. In the NMDA model, higher susceptibility to excitotoxic 590 
neurodegeneration in C57Bl/6-Tyrc and CD-1 mice can be directly related to the lack of 591 
tyrosinase activity and the resulting shortage in L-Dopa – and therefrom synthetized 592 
dopamine – in these mice. In this optic neuropathy model, the Tyr gene modulates extrinsic 593 
susceptibility of RGCs via its profound effect on retinal dopamine levels and melanin 594 
synthesis, which have been shown to confer neuroprotection by regulating physiological 595 
glutamate signaling and restricting glutamate-induced excitotoxicity (Kitaoka et al., 2003; 596 
Palumbo et al., 2000; Safa and Osborne, 2000), by inhibiting NMDA receptor activity 597 
(Castro et al., 1999; Kashii et al., 1994; Kitaoka et al., 2003; Vaarmann et al., 2013), and by 598 
scavenging free radicals (Bilgihan et al., 1995; Corsaro et al., 1995; Porebska-Budny et al., 599 
1992; Scalia et al., 1990; Valverde et al., 1996). Together these tyrosinase-dependent actions 600 
explain the high rate of RGC death in C57Bl/6-Tyrc and CD-1 mice versus pigmented 601 
C57Bl/6 mice. However, with CD-1 mice being far more sensitive than C57Bl/6-Tyrc mice, 602 
an additional interplay of disease-modifying genes encoded in their distinct genetic 603 
backgrounds seems to be at play as well. In contrast, given that axonal lesion is expected to 604 
directly activate apoptosis, the subset of disease-modifying genes can likely be reduced to 605 
intrinsic susceptibility genes in the ONC model (Li et al., 2007; Libby et al., 2005). As these 606 
genes appear to be well-conserved among different genetic lineages (Reed et al., 2003), the 607 
lower complexity of the of the ONC models – in terms of number and interplay of 608 
contributing signaling pathways – might thus explain why genetic background seems to be 609 
sidelined.  610 
On the other hand, comparative studies revealed overlapping gene expression profiles in 611 
murine models of ONC and ocular hypertension-induced glaucoma, indicating that a 612 
glaucomatous insult with many of the same molecular changes is evoked in both models 613 
(Panagis et al., 2011; Schlamp et al., 2001; Steele et al., 2006). This can also be deduced from 614 
the fact that many neuroprotective strategies have been shown to be effective after ONC as 615 
well as ocular hypertension-induced glaucoma. Of note, these therapeutic strategies, e.g. dual 616 
leucine zipper kinase inhibition, neurotrophin supplementation, TNF-α inhibition (Dekeyster 617 
et al., 2015b; Domenici et al., 2014; Fernandes et al., 2014; Roh et al., 2012; Tezel et al., 618 
2004; Welsbie et al., 2013), all act at somal degeneration pathways. Overall, we propose that 619 
the neurodegeneration evoked by ONC mainly appeals to the intrinsic susceptibility of RGCs, 620 
while ocular hypertension-induced RGC death – characterized by a complex interplay of risk 621 
factors that go beyond the acute effects of the elevated IOP-related mechanical injury – is 622 
influenced by a complexity of genetic susceptibility factors, both intrinsic and extrinsic. This 623 
might explain why RGC survival rates were found to diverge in the latter model. Integration 624 
of the data from the ONC and ocular hypertension-induced glaucoma models in this study, 625 
comparing the C57Bl/6 versus CD-1 genetic background, indeed revealed a differential 626 
strain-dependent effect on RGC survival after ONC and LP – i.e. the same RGC death after 627 
ONC, but worse after LP for CD-1. First of all, these findings thus support the concept that 628 
diverging RGC survival is due to factors other than the somal response to any kind of axonal 629 
injury (i.e. intrinsic susceptibility), and is rather related to how and when the injury is 630 
delivered (i.e. to differential involvement of extrinsic susceptibility factors). Second, strain-631 
related differences in RGC survival appear to be more centrally associated with ocular 632 
hypertension-induced glaucomatous damage than broad optic neuropathy models such as 633 
ONC. 634 
Finally, what factors underlie the generally higher susceptibility of CD-1 mice to 635 
glaucomatous RGC death (Cone et al., 2010; Cone et al., 2012; Li et al., 2007)? Current 636 
knowledge of risk factors at play in CD-1 mice, is limited to altered scleral biomechanical 637 
behavior and increased axial length (Cone et al., 2010; Nguyen et al., 2013). Nevertheless, 638 
based on the present findings – relating independent outcomes of the RGC population, visual 639 
projection and visual behavior –, we can suggest several other contributing factors that might 640 
deserve more in-depth investigation in follow-up studies. First, it is to be noted that baseline 641 
IOP appears to be irrelevant in the LP model used, as CD-1 mice – with the lowest IOP of all 642 
three strains – would theoretically be at low risk for developing glaucoma. Second, 643 
(secondary) RGC loss due to excitotoxicity is an integral component of ocular hypertension-644 
induced glaucoma (Almasieh et al., 2012; Casson, 2006). The increased susceptibility to 645 
ocular hypertension-induced RGC death in CD-1 mice might therefore be (partially) related 646 
to their decreased ability to cope with excitotoxic stress – note the similarities in the RGC 647 
survival graphs for the NMDA and LP models (Figure 4a and d). In addition, given the higher 648 
density of RGCs in the retina of CD-1 mice, glutamate release might be manifold and result 649 
in an exponential cascade of paracrine pro-apoptotic signaling. Third, in line with e.g. 650 
(Buckingham et al., 2008; Fahy et al., 2015; Martin et al., 2006; Vidal-Sanz et al., 2012), our 651 
data suggest that RGC axonal transport deficits precede RGC loss in the LP model, and that 652 
early changes in visual function may be caused by axonal dysfunction rather than by cell loss. 653 
Furthermore, this loss in axonal transport integrity and visual acuity appeared to be larger – 654 
already at day 1 post injury – and to progress faster in CD-1 mice, eventually resulting in a 655 
higher RGC death. It remains entirely speculative whether the aberant segregation of 656 
retinofugal axons does confer to this increased susceptibility to axonal injury. Differential 657 
axonal transport rates in albino versus pigmented animals (Lund, 1975), abrogated retrograde 658 
(neurotrophic) support due to mistargeting to neurons in the dLGN and SC – cfr. 659 
developmental refinement of mistargeted retinal projections by BDNF (Ernst et al., 2000; 660 
Schmidt, 2004) –, as well as differential susceptibility to ocular hypertension-induced 661 
damage depending on the anatomical position of the axon in the optic nerve head/visual 662 
projection (Giolli and Creel, 1973; Osborne et al., 2001), are only a few possible explanations 663 
for our observations. Moreover, our behavioral analyses suggest that visual acuity and SC 664 
functionality is already severely disturbed at baseline in CD-1 mice, potentially leading to a 665 
state that is more vulnerable to additional losses of axonal projections. 666 
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Figure captions 952 
Figure 1. 953 
Retinal histology and RGC density in C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice. (a-d) In 954 
vivo OCT scans of C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice. Representative image of N=10 955 
per strain; scale bar: 50 µm. (e-h) Hematoxylin and eosin-stained transverse sections of the 956 
retina of C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice. Representative image of N=4 per strain; 957 
scale bar: 20 µm. (d, h) In our colony, 21% of the CD-1 mice are carrying a homozygous 958 
rd1/rd1 mutation, resulting in a total loss of the outer retinal layers due to photoreceptor 959 
degeneration. (i) A detailed morphometric analysis on retinal sections reveals, upon exclusion 960 
of CD-1 mice carrying the rd1 mutation, no significant differences in the thickness of any 961 
retinal layer (N=4, two-way ANOVA). (j) Evaluation of RGC density on retinal flatmounts 962 
points out a higher number of RGCs per mm² in CD-1 mice (N=10, one-way ANOVA). Data 963 
are presented as mean ± SEM. NFL: nerve fiber layer, GCL: ganglion cell layer; IPL: inner 964 
plexiform layer, INL: inner nuclear layer; OPL: outer plexiform layer, ONL: outer nuclear 965 
layer; PRL: photoreceptor layer; total: thickness of the entire retina, measured from the NFL 966 
till the ONL. 967 
968 
Figure 2. 969 
Anterograde tracing of retinofugal projections to the dLGN in C57Bl/6, C57Bl/6- Tyrc, 970 
and CD-1 mice, within the rostrocaudal region between Bregma -2.10 mm and -2.60 971 
mm. (a) The dLGN is outlined based on a VGluT2 immunostaining. In C57Bl/6-Tyrc and 972 
CD-1 mice, the ipsilateral retinogeniculate projection is more diffuse, as compared to the 973 
C57Bl/6 mice, and the core of the ipsilateral zone within the contralateral dLGN (arrow) is 974 
not well delineated. (b) In C57Bl/6 mice, there is no difference in the density of ipsilateral 975 
versus contralateral RGC axon termini. In contrast, in C57Bl/6-Tyrc and CD-1 mice, 976 
ipsilateral termini are less dense compared to contralateral projections (N=3-4, two-way 977 
ANOVA) [x]. When comparing ipsilateral projections among the three strains, both albino 978 
strains show lower values as compared to the pigmented C57Bl/6 strain (N=3-4, one-way 979 
ANOVA) [y]. In addition, C57Bl/6-Tyrc and CD-1 mice have more contralateral projecting 980 
RGCs terminating within the ipsilateral core (N=3-4, one-way ANOVA) [z]. (c) Transverse 981 
section of the dLGN, with a schematic representation of the theoretical RGC projection 982 
zones, along with the ROIs (cfr. methodology section) in which CTB labeling is analyzed. (d) 983 
Separated from the bulk of contralateral axon terminals, a patch of contralateral termini 984 
(arrowhead) is detected in all four C57Bl/6-Tyrc and in two out of four CD-1 mice. This 985 
phenotype is never observed in C57Bl/6 wild types. (e) In C57Bl/6-Tyrc mice, the density of 986 
these RGC axon terminals in the ROI ‘contra patch’ is higher compared to the density within 987 
the neighboring contralateral zone (N=4, Student’s t-test). Data are presented as mean ± 988 
SEM. 989 
990 
Figure 3. 991 
Anterograde tracing of retinofugal projections to the SC in C57Bl/6, C57Bl/6- Tyrc, and 992 
CD-1 mice, within the rostrocaudal region between Bregma -3.16 mm and -4.84 mm. (a) 993 
The boundary (dotted line) between the visually driven layers of the sSC, including the 994 
stratum zonale (SZ), stratum griseum superficiale (SGS), and stratum opticum (SO), and the 995 
underlying deep SC, is outlined based on a VGluT2 immunostaining. Ipsilateral 996 
retinocollicular projections mainly terminate in the lower sSC. Cross-section 1: clearly 997 
distinct ipsilateral patches in the SO are visible in the rostral sSC of C57Bl/6 and C57Bl/6-998 
Tyrc mice, but this zone is more continuous in CD-1 animals. In addition, in C57Bl/6 and 999 
C7Bl/6-Tyrc mice, a densely labeled small patch of ipsilateral projections is observed in the 1000 
medial SZ (arrowhead). Cross-sections 2 and 3: the rostrocaudal tube-like ipsilateral 1001 
projection zone (arrows) is densely labeled with CTB signal in C57Bl/6 mice, while in both 1002 
albino strains, the CTB signal appears more diffuse. In CD-1 mice particularly, the shape of 1003 
this tube is rather stretched along the lateromedial axis as compared to the round shape in 1004 
C57Bl/6 and C57Bl/6-Tyrc mice. Scale bars: 200 μm. (b) Left: top view on both SCi, dotted 1005 
lines mark the rostrocaudal position of the coronal sections. Right: coronal sections of the 1006 
SCi, illustrating theoretical projections from the CTB-injected eye. (c) Visual acuity in albino 1007 
mice is significantly reduced in comparison to the C57Bl/6 strain. Moreover, CD-1 mice 1008 
display an even worse visual acuity than C57Bl/6-Tyrc mice (N=10, one-way ANOVA). Data 1009 
are presented as mean ± SEM. 1010 
1011 
Figure 4. 1012 
RGC survival in C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice after induction of glaucoma by 1013 
means of intravitreal injection of NMDA, ONC, and LP of the episcleral and perilimbal 1014 
vessels. (a) At 4 dpi of NMDA, C57Bl/6, C57Bl/6-Tyrc and CD-1 mice display significantly 1015 
different RGC survival rates (N=5-9, two-way ANOVA). (b) Survival of Brn3a+ RGCs at 7 1016 
days post ONC is identical in C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice (N=7-11, one-way 1017 
ANOVA). (c) Adjustment of the laser parameters for each strain results in overlapping IOP 1018 
profiles for C57Bl/6, C57Bl/6-Tyrc, and CD-1 mice after LP of the episcleral and perilimbal 1019 
vessels (N=10-11, repeated measures two-way ANOVA). (d) Average survival of Brn3a+ 1020 
RGCs at 14 days post LP is similar in C57Bl/6 and C57Bl/6-Tyrc, yet lower in CD-1 mice 1021 
(N=10-11, one-way ANOVA). Data are presented as mean ± SEM. 1022 
1023 
Figure 5. 1024 
Loss of axonal transport and diminished visual function, precede ganglion cell loss in an 1025 
ocular hypertension-induced glaucoma model. (a) At 14 dpi, C57Bl/6 and C57Bl/6-Tyrc 1026 
versus CD-1 mice display significantly different RGC survival rates (N=9-10, two-way ANOVA). 1027 
The number of Brn3a+ RGCs is expressed relative (%) to the number of Brn3a+ RGCs in naive 1028 
retinas. (b) A similar trend, i.e. higher disease severity in CD-1 mice compared to the C57Bl/6 1029 
background, is seen when axonal transport integrity is evaluated by means of OHSt retrograde 1030 
labeling at 4 dpi (N=7-9, two-way ANOVA). The number of OHSt+ RGCs is expressed relative (%) to 1031 
the number of OHSt+ RGCs in naive retinas. (c) At 4 dpi, no RGC death is observable, while the first 1032 
signs of axonal transport deficits are emerging. As a result, all RGCs retain Brn3a labeling yet only a 1033 
subset can still be visualized via retrograde labeling with OHSt. Arrow: example of Brn3a+ OHSt- 1034 
RGC. Scale bar, 50 µm. (d) Visual acuity starts to decrease as soon as 1 dpi, and this deterioration in 1035 
visual function appears to progress faster in CD-1 mice as compared to C57Bl/6-Tyrc mice (N=8-10, 1036 
two-way ANOVA). Data are presented as mean ± SEM. 1037 
